UBS set a €23.60 ($29.14) price target on AXA (EPA:CS) in a research note issued to investors on Wednesday, April 4th, www.boersen-zeitung.de reports. The firm currently has a neutral rating on the stock.
Several other research analysts have also recently issued reports on CS. DZ Bank reaffirmed a neutral rating on shares of AXA in a report on Thursday, December 28th. JPMorgan Chase set a €29.20 ($36.05) target price on shares of AXA and gave the company a buy rating in a research note on Tuesday, January 30th. Royal Bank of Canada set a €29.00 ($35.80) price target on shares of AXA and gave the company a buy rating in a report on Tuesday, January 16th. Kepler Capital Markets set a €28.30 ($34.94) price objective on shares of AXA and gave the stock a buy rating in a report on Tuesday, March 13th. Finally, Citigroup set a €24.10 ($29.75) price objective on shares of AXA and gave the stock a neutral rating in a report on Tuesday, March 20th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of €27.40 ($33.83).
Shares of EPA:CS opened at €22.80 ($28.15) on Wednesday. AXA has a 12 month low of €22.13 ($27.32) and a 12 month high of €27.69 ($34.19).
WARNING: This article was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://stocknewstimes.com/2018/04/14/ubs-analysts-give-axa-cs-a-23-60-price-target-2.html.
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.